Generation Bio Co. (GBIO)

Feb 9, 2026 - GBIO was delisted (reason: acquired by XOMA)

5.34

-0.40 (-6.97%)

Inactive · Last trade price on Feb 6, 2026

Generation Bio Co. Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-62.63	-131.67	-126.61	-136.64	-119.15	-80.52
Depreciation & Amortization	4.85	4.93	5.26	5.13	4.53	3.43
Stock-Based Compensation	8.84	14.61	24.34	24.45	17.86	8.41
Other Adjustments	-4.12	54.99	-9.27	3.56	0.77	0.25
Change in Receivables	1.82	-1.22	-3.57	-0.4	-	0.45
Changes in Accounts Payable	0.42	-0.39	1.09	-1.39	1.76	-1.44
Changes in Accrued Expenses	4.77	-7.96	4.29	0.8	1.83	3.43
Changes in Unearned Revenue	-12.01	-15.12	41.6	-	-	-
Changes in Other Operating Activities	-37.13	-6.74	10.13	2.03	0.59	-4.14
Operating Cash Flow	-113.65	-88.56	-52.75	-102.45	-91.82	-70.14
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Capital Expenditures	-	-2.4	-7.4	-8.8	-5.96	-5.52
Sale of Property, Plant & Equipment	0.52	0.2	-	-	0.11	-
Purchases of Investments	-85.72	-135.27	-405.3	-323.71	-	-243.18
Proceeds from Sale of Investments	200	232	403	140	198.9	43.5
Investing Cash Flow	113.72	94.53	-9.7	-192.52	193.05	-205.2

Financing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Issuance of Common Stock	-	0.44	36.55	1.26	215.63	217.47
Repurchase of Common Stock	-0.02	-0.19	-0.57	-0.58	-	-
Net Common Stock Issued (Repurchased)	-0.02	0.25	35.98	0.68	215.63	217.47
Issuance of Preferred Stock	-	-	-	-	-	108.85
Net Preferred Stock Issued (Repurchased)	-	-	-	-	-	108.85
Other Financing Activities	-	-	-0.16	-0.05	-0.96	-3.23
Financing Cash Flow	0.22	0.25	35.82	12.99	214.67	323.1

Net Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Cash Flow	0.28	6.22	-26.63	-281.97	315.9	47.76
Beginning Cash & Cash Equivalents	23.81	72.24	98.86	380.84	64.94	17.18

Free Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Free Cash Flow	-113.65	-90.96	-60.14	-111.25	-97.78	-75.66
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-744.28%	-457.29%	-1018.67%	-	-	-
Free Cash Flow Per Share	-16.95	-13.65	-9.33	-19.14	-17.37	-27.76
Levered Free Cash Flow	-101.72	-159.34	-71.64	-138.87	-116.4	-84.77
Unlevered Free Cash Flow	-108.89	-170.07	-83.6	-143.41	-116.35	-85.36

SEC Filings: 10-K · 10-Q